Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Lumishade® Active Lens NCT04904328 · A Proof of Concept Alleviating the Symptoms of Photosensitive Migraine. | Migraine | Traitement symptomatique | Non applicable | UNKNOWN | This proof of concept clinical study will investigate the efficacy of acti… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:23 | Détail |
| Nerivio Migra-1 active device NCT03361423 · Evaluation of a Novel Device for Treatment of Migraine Headache | Migraine | Traitement symptomatique | Non applicable | COMPLETED | Migraine is a common neurologic with attacks of headache and associated sy… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:23 | Détail |
| Atogepant NCT03939312 · Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogep… | Migraine | Traitement symptomatique | Phase 3 | COMPLETED | A migraine attack is a moderate or severe headache that usually occurs on… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Atogepant NCT03777059 · 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Mi… | Migraine | Traitement symptomatique | Phase 3 | COMPLETED | A migraine attack is a moderate or severe headache that usually occurs on… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| CGRP NCT01924052 · CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load | Migraine | À vérifier | Non applicable | COMPLETED | The investigators hypothesized that migraine without patients with many ge… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Dihydroergotamine NCT05337254 · A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal… | Migraine | À vérifier | Phase 1 | COMPLETED | Study STS101-007 is a randomized, double-blind, parallel group, placebo-co… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Erenumab NCT05281770 · Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study | Migraine | Traitement symptomatique | À vérifier | UNKNOWN | The primary objective of this study is to evaluate the treatment benefit o… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Lasmiditan NCT03962738 · MONONOFU — A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese… | Migraine | À vérifier | Phase 2 | COMPLETED | The purpose of this study is to evaluate the efficacy and safety of a rang… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| MINDKIDS — Mindfulness for Adolescents for CM and HFEM NCT04968093 · NCT04968093 | Migraine | Ralentissement de la progression | Non applicable | COMPLETED | Chronic Migraine (CM) and High Frequency Episodic Migraine (HFEM) without… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Optical coherence tomography (OCT) NCT05332431 · Optical Coherence Tomography Findings in Migraine | Migraine | À vérifier | À vérifier | UNKNOWN | This study aims to detect changes in RNFL thickness in patients with diffe… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| PERCAM — Brain Perfusion Assessment in the Acute Phase of Migraine Au… NCT03821584 · NCT03821584 | Migraine | À vérifier | À vérifier | TERMINATED | The aim of the study is to determine the proportion of patients with chang… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Rimegepant NCT03266588 · Open Label Safety Study in Acute Treatment of Migraine | Migraine | À vérifier | Phase 2/3 | COMPLETED | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Rimegepant NCT03237845 · Safety and Efficacy in Adult Subjects With Acute Migraines | Migraine | À vérifier | Phase 3 | COMPLETED | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Rimegepant NCT03235479 · Safety and Efficacy Study in Adult Subjects With Acute Migraines | Migraine | À vérifier | Phase 3 | COMPLETED | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Sildenafil NCT02795351 · Induction of Migraine Aura With Sildenafil | Migraine | À vérifier | Phase 1 | COMPLETED | This study is done to evaluate whether treatment with the drug sildenafil… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Tailored Digital Treatment for Migraine NCT05617339 · NCT05617339 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | UNKNOWN | Background: An individualized internet-based treatment program from a biop… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Transcutaneous Supraorbital Nerve Stimulator NCT05516251 · Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of… | Migraine | À vérifier | Non applicable | UNKNOWN | Migraine has been ranked as the second most disabling neurological disorde… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:22 | Détail |
| Levcromakalim NCT04905654 · Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura | Migraine | À vérifier | Non applicable | COMPLETED | This study aims to explore the effect of Ivabradine on Levcromakalim-induc… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:21 | Détail |
| Biofeedback NCT05454319 · CER-MIG-1 — Cerebri Biofeedback Feasibility Trial | Migraine | Thérapie génique | Non applicable | COMPLETED | The purpose of this study is to investigate feasibility, usability, safety… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:20 | Détail |
| DFN-15 Active NCT03006276 · Efficacy, Tolerability, and Safety Study of DFN-15 | Migraine | À vérifier | Phase 3 | COMPLETED | Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:20 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migrai… Sumatriptan 50 mg · PMID 38886287 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Around 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or med… | Pain and therapy 2026-08-16 21:22:02 | Source |
| Comparing the efficacy of eletriptan for migraine in women during men… Eletriptan 20 mg · PMID 24256184 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source To assess the efficacy and tolerability of eletriptan in treating migraine attacks occurring within the defined menstru… | Headache 2026-08-16 21:22:01 | Source |
| Economic analysis of triptan therapy for acute migraine: a Medicaid p… Eletriptan 20 mg · PMID 17655509 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To compare triptan therapies for migraine in terms of the cost to treat 100 migraine attacks and the cost per successfu… | Pharmacotherapy 2026-08-16 21:22:01 | Source |
| Perimenstrual eletriptan prevents menstrual migraine: an open-label s… Eletriptan 20 mg · PMID 20236337 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source To prospectively evaluate the efficacy of perimenstrual prophylaxis with eletriptan to reduce headaches in women identi… | Headache 2026-08-16 21:22:01 | Source |
| Massively parallel single-cell chromatin landscapes of human immune c… CBD 200 mg OD · PMID 31375813 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Understanding complex tissues requires single-cell deconstruction of gene regulation with precision and scale. Here, we… | Nature biotechnology 2026-08-16 19:26:32 | Source |
| Motor function of the opossum sphincter of Oddi. CBD 200 mg OD · PMID 6822661 | Migraine | À vérifier | Publication | PubMed | Voir la publication source We studied the opossum sphincter of Oddi (SO) because in this species the SO is approximately 3 cm in length and its ex… | The Journal of clinical investigation 2026-08-16 19:26:32 | Source |
| Cannabidiol Attenuates Heroin Seeking in Male Rats Associated With No… CBD 100 mg OD · PMID 40992584 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Opioid use disorder is a chronic relapsing condition characterized by cycles of compulsive drug use, abstinence, and re… | Biological psychiatry 2026-08-16 19:26:31 | Source |
| Maternal ingestion of cannabidiol (CBD) in mice leads to sex-dependen… CBD 100 mg OD · PMID 39481653 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source The consequences of perinatal cannabidiol (CBD) exposure are severely understudied, but are important, given its widesp… | Pharmacology, biochemistry, and behavior 2026-08-16 19:26:31 | Source |
| 1-Deoxynojirimycin attenuates diabetic cardiomyopathy via PI3K/AKT-me… Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Contro… | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Publication | PubMed | Voir la publication source 1-Deoxynojirimycin (DNJ), a naturally occurring alkaloid derived from mulberry leaves (Morus alba L.), is a powerful α-… | Journal of ethnopharmacology 2026-08-16 19:26:30 | Source |
| Zhenwu Decoction ameliorates experimental benign prostatic hyperplasi… Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Contro… | Migraine | Remyélinisation indirecte / réparation · Neuroprotection · Traitement symptomat… | Publication | PubMed | Voir la publication source Zhenwu Decoction (ZWD), first recorded in the Shang Han Lun, is a classical formula used to warm Yang and promote water… | Journal of ethnopharmacology 2026-08-16 19:26:30 | Source |
| A Randomized Controlled Trial of Instillation Protocols Prior to Intr… onabotulinumtoxinA prophylaxis with Lidocaine · PMID 40025238 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Achieving adequate pain relief is crucial for intradetrusor onabotulinumtoxinA treatments for idiopathic overactive bla… | International urogynecology journal 2026-08-16 19:26:28 | Source |
| A phase 1, multicenter, open-label study to evaluate the pharmacokine… Rimegepant 75 mg ODT · PMID 41133671 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To evaluate pharmacokinetics (PK), safety, and tolerability of a weight-adjusted dose of rimegepant orally disintegrati… | Headache 2026-08-16 19:26:27 | Source |
| A randomized open-label study to evaluate the effectiveness and safet… Rimegepant 75 mg ODT · PMID 40734466 | Migraine | À vérifier | Publication | PubMed | Voir la publication source AimTo evaluate rimegepant, a calcitonin gene-related peptide receptor antagonist, for short-term prevention of fasting-… | Cephalalgia : an international journal of headache 2026-08-16 19:26:27 | Source |
| Rimegepant for acute treatment of migraine in triptan-unsuitable adul… Rimegepant 75 mg ODT · PMID 41255093 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source BackgroundA subset of individuals with migraine are unsuitable for triptans due to intolerance, lack of efficacy, or co… | Cephalalgia : an international journal of headache 2026-08-16 19:26:27 | Source |
| Decoding the serotonin-alcohol crosstalk: the role of central seroton… Serotonergic Psychedelic · PMID 42329577 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Serotonin (5-hydroxytryptamine; 5-HT) is a key neuromodulator involved in the regulation of mood, appetite, aggression,… | Pharmacological reports : PR 2026-08-16 19:26:26 | Source |
| Proliferative Effects of the Psychedelic N,N-Dimethyltryptamine (DMT)… Serotonergic Psychedelic · PMID 42427129 | Migraine | Thérapie cellulaire | Publication | PubMed | Voir la publication source The serotonergic psychedelic N,N-dimethyltryptamine (DMT) produces rapid antidepressant effects in preclinical and earl… | ACS chemical neuroscience 2026-08-16 19:26:26 | Source |
| Botulinum toxin effects on biochemical biomarkers related to inflamma… Tear Biomarkers for Migraine · PMID 40035830 | Migraine | Neuroprotection · Immunomodulation · Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Botulinum toxin type A (BoNT) has emerged as a potential alternative to conventional therapies to many debilitating chr… | Journal of neural transmission (Vienna, Austria : 1996) 2026-08-16 19:26:25 | Source |
| Feasibility and Tolerability of Psilocybin for Phantom Limb Pain. Serotonergic Psychedelic · PMID 42567236 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Phantom limb pain (PLP) is a refractory condition defined by pain experienced in a missing limb. Psilocybin, a classica… | The journal of pain 2026-08-16 19:26:25 | Source |
| The ocular surface tear film as a biomarker for systemic health. Tear Biomarkers for Migraine · PMID 40345388 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The tear film is a complex structure with rich interactions with the human body. A growing body of evidence suggests th… | The ocular surface 2026-08-16 19:26:25 | Source |
| [Clinical practice guideline for migraine with traditional Chinese me… Yangxue Qingnao Granules (Pills) · PMID 33350221 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source The present clinical practice guideline was written by experts organized by the special group of key projects in the 13… | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi =… 2026-08-16 19:26:24 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |